Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EBIT Growth

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EBIT Growth(%) 298.54-62.910.46-30.07-6.49

What is the latest EBIT Growth ratio of NATCO PHARMA ?

The latest EBIT Growth ratio of NATCO PHARMA is 298.54 based on Mar2023 Consolidated results.
Year EBIT Growth
Mar2023298.54
Mar2022-62.91
Mar20210.46
Mar2020-30.07
Mar2019-6.49

How is EBIT Growth of NATCO PHARMA Trending?

Years EBIT Growth % Change
Mar2023 298.54
Positive
Mar2022 -62.91
Negative
Mar2021 0.46
Positive
Mar2020 -30.07
Negative
Mar2019 -6.49 -

Other Financial Ratios of NATCO PHARMA


Compare EBIT Growth ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹18,277.2 Cr 2.1% 2.1% 65.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹356,673.0 Cr -2.9% 0% 59.6% Stock Analytics
CIPLA ₹119,930.0 Cr 5.8% 6.2% 60.9% Stock Analytics
DIVIS LABORATORIES ₹109,446.0 Cr 5% 8% 25.9% Stock Analytics
ZYDUS LIFESCIENCES ₹108,261.0 Cr -2.6% 15.3% 114.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,830.6 Cr 0.9% -1.5% 32.2% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

2.1%

2.1%

65.5%

SENSEX

2%

2.3%

22.2%


You may also like the below Video Courses